Specific pathogen-free cats were infected with the Maryland strain of FIV (FIV-MD) for the purpose of assessing the effects of FIV infection on the central nervous system (CNS). Two separate studies were performed, involving a total of 13 infected cats and six age-matched, sham-inoculated controls. All animals infected with FIV-MD seroconverted by 8 weeks postinfection and virus was recovered from peripheral blood mononuclear cells of all infected cats. All of the infected animals had lower absolute CD4 + cell counts and decreased CD4+/CD8 ÷ ratios. Virus was recovered from the cerebrospinal fluid (CSF) of certain infected individuals, and antiviral antibody and pleocytosis were evident in the CSF of the majority of infected cats.
Introduction
The incidence of AIDS is continually increasing throughout the world. Up to 80 % of human immunodeficiency virus (HIV)-infected people have brain lesions typical of this viral infection and up to 40% develop HIV-1-associated cognitive/motor complex (Elder & Sever, 1988) . However, the underlying pathophysiology of the central nervous system (CNS) effects are not fully understood. To gain a better appreciation of the neurological aspects of the disease and to devise therapeutic approaches directed towards this form of the disease, animal models will be required.
Feline immunodeficiency virus (FIV), first described in 1987 (Pedersen et al., 1987) , is known to cause a disease in cats that is very similar to human AIDS. As in HIV infection, neurological involvement is also noted with FIV infection (Pedersen et al., 1987; Dow et al., 1990; Egberink et al., 1988; Hurtrel et al., 1992; Podell et al., 1993) . Dow and co-workers were the first to report that cats experimentally infected with FIV developed a productive infection of the brain when inoculated by either the intracerebral or peripheral route (Dow et al., 1990) . Virus was isolated from tissue explants from the cerebral cortex, caudate nucleus, midbrain, cerebellum, rostral and caudal brainstem but not fi'om the choroid plexus (Dow et aI., 1990) . Pathological examination of two cats, at 7 months post-inoculation, revealed perivascular infiltrates of mononuclear cells, diffuse gliosis, glial nodules and white matter pallor. These lesions were primarily located in the caudate, midbrain and rostral brainstem (Dow et al., 1990) . Primary cultures of the microglia and astrocytes were productively infected with FIV in vitro. However, similar cultures of neurons, oligodendrocytes and choroid plexus cells showed no evidence of infection. Another study examined the time course of the FIV-induced CNS lesions (Hurtrel et al., 1992) and demonstrated that CNS lesions were seen as early as 1 month post-infection when the virus was given intracerebrally, and as early as 2 months post-infection when the virus was inoculated intravenously. CNS entry for FIV, like HIV (Davis et al., 1992) , is an early event, even when inoculation is peripheral (Podell et al., 1993; Wheeler et al., 1992) . Thus it can be concluded from these studies that FIV infects the CNS and causes pathological lesions that are similar to HIV-induced pathology.
In addition to the neuropathological changes associ- 
Methods
Animals. Specific pathogen-free (SPF) cats were obtained from Liberty Laboratories. Two separate studies were performed. In Study 1, six SPF 5-month-old animals were placed into either a control group (two animals) or a treatment group (four animals). The two groups of cats were communally housed in different rooms. This method of housing fosters animal interactions and helps to create a mentally stimulating environment. Study II was conducted in a manner similar to Study I, with the exception that the cats were 10 weeks old at the time of infection and that the control group consisted of four animals, whereas the FIV-inoculated group contained nine animals. Eight of the latter group were inoculated with virus-containing tissue culture supernatant as detailed below; one cat (no. 11) received 1 ml whole blood from cat no. 1 of Study I. Seroconversion rate and disease course in cat no. 11 were similar to those observed in the other infected animals.
Virus inoculations. FIV-MD was employed in these studies. This viral strain was obtained from a young (2 years old) feline leukaemia virus (FeLV)-negative cat. This cat was severely ill with signs that are consistent with the FIV disease syndrome. The virus was isolated and amplified by co-cultivating this cat's peripheral blood mononuclear cells (PBMCs) with SPF cat PBMCs. The TCIDs0 was determined by serial dilution of the virus in SPF cat PBMCs and monitoring the dilutions for reverse transcriptase (RT) activity. The TCIDs0 was then calculated by determining the dilution at which 50 % of the cultures had RT activity (Reed & Muench, 1938) . On the day before and the day of infection, both groups were injected with methylprednisolone at 4.0 mg/kg. This pretreatment of the animals with a glucocorticosteroid, prior to infection, has been used with FeLV to enhance the extent of the viral infection (Rojko et al., 1979) . The infected group was intravenously inoculated with 1000 TC1Ds0 units of the FIV-MD strain. The control group received an injection of tissue culture medium from uninfected cells.
Physical and neurological examinations. All cats received routine physical and neurological examinations approximately once a month for the duration of the studies. The neurological examination consisted of an overall assessment of their mental state, behaviour, gait and posture. Additionally, palpebral, menace, pupillary, patellar, hopping, wheel-barrowing and righting reflexes were assessed as were eye positions, lip tone, tone of the masticatory muscles and conscious proprioception (Ettinger, 1983) .
Virus isolation. Ten ml of whole blood was collected by jugular puncture. The mononuclear cells were isolated over a Ficoll-Hypaque gradient as previously described (Pedersen et al., 1987) . Cells were cultured in RPMI containing 10% fetal bovine serum with 1000 U of recombinant human interleukin-2 (IL-2), kindly provided by Hoffmann-La Roche. At weekly intervals, 5 ml of culture supernatant was assayed for the presence of particle-associated RT activity, as previously described (Pedersen et al., 1987) . Cultures were presumed to be negative if RT activity was not detected by the sixth week of incubation. Virus isolation from the brain was performed by first placing the animal into a deep plane of anaesthesia (Ketalar, ketamine hydrochloride, 15 mg/kg), perfusing the brain with cold saline, rapidly removing the brain and making explant cultures that were co-cultivated with SPF cat PBMCs. Cerebrospinal fluid (CSF) was obtained by cisterna magnum puncture. Virus isolation from the CSF was performed by pelleting of cells from the CSF and separately cocultivating the CSF cells or cell-free CSF with indicator PBMCs and monitoring for RT activity.
Antibody determination. FIV antibody titre was determined by ELISA. Briefly, 50 ng of gradient-purified FIV was added to each well (96-well half-area ELISA plate, Costar). The antigen, in PBS, was allowed to dry onto the plate and was then methanol-fixed. The plate was then blocked with BLOTTO (Johnson et al., 1983) for 1 h at 37 °C. The sera were added to the plate in twofold dilutions and allowed to incubate for 1 h at 37 °C. The plate was then washed with PBS-0.05 % Tween 20. Rabbit anti-feline IgG-peroxidase conjugate (Fisher Biotech) was added at a dilution of 1 : 1000 and incubated for 1 h at 37 °C. The plate was washed, developed using 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) chromogenic substrate (ABTS) and read at 405 nm. Specificities of the antibodies for FIV proteins were established by Western blot analysis using gradient-purified virus as target antigen, as previously described (Johnson et al., 1983) .
CD4 + and CD8 + cell determinations. Lymphocyte subtyping was performed as follows. Whole blood was fractionated over a FicollPaque (Pharmacia) gradient. The PBMCs were collected and washed twice with RPMI and counted. Two-million cells were taken from each specimen. One-million cells were labelled and the other million cells were used as non-labelled controls. The cells were incubated for 30 min on ice with the anti-feline CD8-biotin-conjugated antibody (Southern Biotechnology Associates). The cells were washed twice with cold Earle's balanced salt solution (EBSS). Following this wash, the cells were incubated in the dark for 30 min at 4 °C with anti-feline CD4 FITC-labelled antibody (Southern Biotechnology Associates), as well as avidin-conjugated phycoerythrin (Southern Biotechnology Associates). The cells were then washed twice in EBSS and resuspended in 1 ml of EBSS with 1% formaldehyde. The percentages of CD4 + and CD8 ÷ cells were determined by fluorescence-activated cell sorting (FACS). Absolute CD4 + and CD8 + cell counts were calculated by multiplying the total lymphocyte number by the percentages of each subtype.
Auditory and visual evoked potentials. Ketamine hydrochloride-(10 mg/kg intramuscular) anaesthetized felines were aseptically fitted with subcutaneous monopolar needle electrodes (TECA Intropak DMG-50) to record brainstem auditory evoked potentials (BAEPs) and visual evoked potentials (VEPs) differentially. The two active electrodes were placed centrally near the vertex and on the midline over the frontal sinus, respectively. The ground (earth) electrode was placed in the nuchal muscles. For BAEPs, felines were then fitted with bilateral polyethylene ear tubes placed into the external auditory canal. A 'Y'-connector attached the two tubes to the central sound source (Grass Instruments Audio Amplifier). A computer program written using National Instruments software ('LabView') for the Macintosh II microcomputer was used to generate the stimuli and to collect the data. The sound stimulus consisted of a 70 dB click generated by a 100 gs input to the audio amplifier. Raw signals were amplified by a Grass P-511 instrumentation amplifier filtered between 300 and 3000 Hz and averaged using custom software operating on a Macintosh II series computer. Stimuli were delivered binaurally at a frequency of 10 per second for a total of 1024 stimuli. On-line averaging of the signals allowed us to repeat trials within a recording session to determine the stability of the evoked responses.
For VEPs, stimuli were elicited by a Grass clinical photostimulator set on the highest intensity (setting 12). Two methods were employed. First, cats were binocularly stimulated at a rate of one stimulus flash per second with the light source 30 cm from the nose. Responses to 100 stimuli were averaged for each recording session. One replication was done for each experiment to evaluate stability of the evoked events. Ambient room lighting remained on. As with auditory stimulation the visual stimuli and data acquisition were controlled by a Macintosh II computer. For the second method, each eye was individually stimulated (monocular stimulation) while the other eye was manually covered by an opaque cup.
Evoked events were analysed on-line using signal averaging capabilities of a Macintosh II microcomputer using custom-made LabView software. Averaged peak latencies and amplitudes were calculated and compared individually between animals and as group means using ANOVA and Sheff~ post hoc statistical tests.
Sleep studies. Two felines from the first experimental group (one infected and one control) were anaesthetized with ketamine hydrochloride, intubated and surgically prepared for sleep recording by implanting cortical stainless steel electrodes in the cranial vault. In addition, bipolar stainless screw electrodes were placed in the frontal sinus to record eye movements. Bipolar nichrome leads (250 gm in diameter) insulated except for the wire tips were placed in the nuchal musculature to monitor electromyographic activity. All leads were cemented to the cranial vault by dental cement and brought together in a connector assembly (amphenol) for later monitoring of electrical activity. Felines were given 2 weeks of recovery and subsequently acclimatized for a minimum of 3 days to an environmental chamber (BRS/LVE Large animal cubicle 89 cm height x 86 cm width x 74 cm depth) containing a 60 cmx 60 cm rug and a litter pan, prior to sleep recording. Felines were sequentially recorded for 3 consecutive days from 8 a.m. to 5 p.m. Two channels of electroencephalographic (EEG) activity were recorded on a Grass model 78 polygraph in addition to one channel each of electromyographic and eye movement activity. EEG activity was simultaneously recorded on an instrumentation tape recorder (Vetter) for later off-line analysis of EEG frequency spectra.
EEG data analysis included the initial visual inspection of the recorded channels of the EEG to determine on-going quality and appearance of spontaneous waveforms. Further analysis included the determination of latency, duration, and percentage of total sleep time of discrete sleep states. These measures were calculated and displayed off-line using computer software (Somnibus).
Histopathology. Animals were deeply anaesthetized with ketamine hydrochloride/Rompine, followed by perfusion through the left ventricle with either 4 % paraformaldehyde (one control and one FIVinfected cat), or a sterile physiological saline solution (one FIV-infected cat) drained through the right atrium. For the animals perfused with paraformaldehyde, sections of brain and spinal cord, as well as vital organs, were post-fixed in 4 % paraformaldehyde for 6 h, transferred to 70% ethanol, and embedded in paraffin. Representative samples of brain were taken aseptically for culture from the saline-perfused FIVinfected cat (see above). Other sections of brain, spinal cord and vital organs were immersion-fixed in 10% zinc-formalin for 24 h, transferred to 70 % ethanol and embedded in paraffin wax. Five gm sections from each block were stained with haematoxylin/eosin, and luxol fast blue/periodic acid Schiff stains for microscopical evaluation.
Results
Two independent studies were initiated to assess the infection of the CNS by FIV. In Study I, four animals were infected with 1000 TCIDs0 units of FIV-MD and two non-contact controls were inoculated with tissue culture supernatant from uninfected cells. In study II, nine animals were infected with FIV-MD and four shaminoculated controls were employed. All of the infected cats from both studies became virus isolation-positive and developed anti-FIV antibodies in their serum by 6 weeks post-infection, whereas the non-contact control animals remained seronegative (Fig. 1) . Relatively high levels of antiviral antibody persisted in the blood of FIV + animals throughout the course of the study. In vitro cultivation of PBMCs from all infected cats of both studies resulted in recovery of FIV. Polymerase chain reaction (PCR) analyses, followed by nucleotide sequencing of the products, were used to verify that virus recovered from these animals was FIV-MD (not shown).
In both studies, a decrease in the CD4+/CD8 + ratio occurred in the infected group relative to the control findings in both the physical and neurological examinations. Particularly relevant to this study was that the neurological abnormalities (delayed pupillary and righting reflexes and anisocoria) were confined to the FIVinfected animals. Anisocoria first appeared at 3 months post-infection, and in most cats persisted throughout the study. However, the lesion spontaneously regressed in one animal 10 months post-infection. The delayed righting reflex was first noted at 8 weeks post-infection and was intermittently detected throughout the study in affected animals. Delayed pupillary responses were first noted at 16 weeks post-infection. The condition persisted throughout the study in two of the three affected animals and was intermittently detected in the third affected cat. The anisocoria is a particularly interesting lesion as it occurred in 10 of the 13 FIV-infected cats. This abnormality reflected an inability of the iris to constrict completely in response to either a direct or consensual light stimulus. When the cats were placed in a darkened room, the pupils of both eyes dilated normally. Thus, the ability of the iris to dilate was unimpaired. Ophthalmological examination revealed no other abnormalities. To localize this lesion further, physostigmine and cocaine were applied to the eye on different days (Adler, 1957) . Cocaine prevents the re-uptake of the sympathetic mediator, norepinephrine (noradrenalin). Accumulation of norepinephrine results in dilation of the iris. Physostigmine blocks cholinesterase locally, allowing the parasympathetic mediator, acetylcholine, to accumulate at nerve end plates and cause a prolonged stimulation of the iris constrictor muscle. The expected ocular effect was seen with both cocaine and physostigmine in both the control and the FIV-infected cats. A normal cocaine ? * ' ~ " effect was expected as the abnormal eyes were able to dilate normally in a darkened room. However, physostigmine's effect of equally constricting the eyes o f both the anisocoric (infected) and the control cats indicates that the lesion is not in either the iris or the lower parasympathetic neuron, but rather is mostly likely to be within the CNS. Although it is difficult to quantify, at least two of the FIV-infected cats underwent a severe behavioural change that correlated with their onset of anisocoria. Both cats no. 1 and 6 changed from actively seeking h u m a n contact to a reclusive type of behaviour for no. 1, and no. 6 also exhibited a more solitary behaviour along with greater aggression.
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In the CSF, antibodies to F I V were detected in most o f the infected cats (Table 2) . Marked pleocytosis was also observed in cats 11, 13 and 17. F I V was recovered from the CSF of three o f the nine virus-inoculated cats via cocultivation with uninfected P B M C s in the presence of IL-2 (Table 2) .
Virus was isolated from the cerebral cortex, midbrain and cerebellum o f an FIV-infected cat (cat no. 12, data not shown). Further molecular evaluation of virus recovered from these tissues is in progress. Similar to what has been previously described (Dow et al., 1990; Hurtrel et al., 1992) , histopathological examination of two infected cats revealed mild histopathology which was not observed in sections from a control animal. In animal no. 12, glial nodules were present in the parahippocampal gyrus, whereas perivascular cell infiltrates were present in cortical and subcortical regions, as well as in the brainstem (Fig. 3) . In the other infected animal (no. 2), a minimal perivascular infiltrate was found in the anterior Sylvian gyrus.
To examine neurological function, visual and auditory evoked responses, E E G as well as sleep disturbances were investigated. Brainstem auditory and visual evoked event measurements were initially made on four FIV-MD-infected cats and two age-matched control cats from 6 months to 13 months post-infection. Three separate recordings were made over a period of five months from 8 to 12 months post-infection. Although the sample numbers were small, modest average delays were observed in specific positive peak waveforms in the FIV-infected subjects compared with controls. Because o f these encouraging results, we studied a second group of four control and nine F I ¥ -M D -i n f e c t e d cats using the Fig. 6 . Illustration of the sleep architecture in one normal (no. 3) and one FIV-infected (no. 1) cat. Latency for sleep onset is substantially increased. Slow-wave sleep 2 is augmented, whereas rapid eye movement (REM) sleep frequency is reduced. methods described above. These tests were conducted initially 6 months post-inoculation. Fig. 4 and 5 illustrate the electrophysiological findings in this new cohort of subjects. Similar to the pilot investigation, significant delays were observed in specific components of the FIV-MD-infected cats' auditory and visual evoked responses compared to those of controls. Particularly striking is the delay in the auditory 'P3' and 'P4' waveforms of the FIV-infected cats compared to controls (Fig. 4) and the visually evoked 'P3' wave in the FIV-infected group (Fig. 5) . Similar findings have recently been reported by Podell et al. (1993) .
In addition to the evoked potential studies, one control cat and one FIV-infected cat were surgically implanted with permanent nichrome screw electrodes to assess further the potential EEG abnormalities and sleep-wake changes previously observed in human HIV-infected subjects (St. Kubicki et al., 1988; Norman et al., 1988 Norman et al., , 1990 Norman et al., , 1992 . Nine electrodes were placed in the skull and nuchal musculature and were mounted in an acrylic headmount to monitor behavioural state. Preliminary analysis of the raw EEG did not suggest major differences in the two cats. However, sleep-related slowing of the dominant EEG frequencies was greater in the FIVinfected animal. Analysis of 8 h sleep recordings from the two subjects revealed dramatic changes in sleep parameters in the FIV-infected cat compared to the control. 
Discussion
The findings of this study indicate that FIV infection of the feline CNS closely parallels the effects that HIV exerts on the human nervous system. In this study, we show that FIV produces a neurological disease early in the course of infection. Examination of the infected cats revealed numerous functional abnormalities including delayed righting and pupillary reflexes, anisocoria, altered visual and auditory evoked potentials and abnormal sleep patterns. These findings are consistent with those described for HIV infection in humans which can cause alterations in both visual (Malessa et al., 1989) and auditory (Goodin et al., 1990; Boccellari et al., 1993; Smith et al., 1988; Pagano et al., 1992; Rosenhall et al., 1989; Koralnik et al., 1990; Jabbari et al., 1993) evoked potentials. In addition, abnormal sleep patterns, similar to the findings of this study, have also been reported in HIV-infected individuals (Aldrich et al., 1988; St. Kubicki et al., 1988; Rothenberg et at., 1990; Norman et al., 1988 Norman et al., , 1990 Norman et al., , 1992 . Finally, decreased coordination and slowed reflexes are common in HIV-infected individuals (Karlsen et al., 1992; Orefice et al., 1991) . Thus, it would appear that FIV infection of the feline CNS causes neurological dysfunction that is similar to the effects HIV exerts on the human nervous system (also see Podell et al., 1993) .
Although anisocoria has been associated with HIV (Poutiainen et al., 1991) and FIV infection (Hopper et al., 1989) , it has not been a predominantly reported clinical finding with either viral infection. The high incidence of anisocoria observed in this study may reflect a viral strain predilection to cause anisocoria or possibly a genetic susceptibility of the cats used in this study to develop this lesion. An alternative possibility is that anisocoria may have been overlooked in a number of studies and thus the incidence with HIV infection may be higher. Also, since we observed reversion of the lesion in some individuals in the late acute phase, it may be that this abnormality reverts in a number of HIV-infected individuals prior to close examination by a physician.
FIV produced detectable neurological abnormalities early during the infection. At least some of these altered parameters were reversible. However, no reversion of the delayed auditory and visual evoked potentials has been observed in our studies to date. Thus, these indices remain consistent for the monitoring of FIV infection of the CNS. However, the demonstration that some of the neurological functions studied returned to normal and that there is minimal histopathology early in the course of the disease indicates that if effective therapy were initiated early in the disease process, prior to permanent impairment, that neurological dysfunction may be prevented or possibly returned to normal. Additional evidence to support this assertion is that 3'-azido-3'-deoxythymidine (AZT) has been shown to have an ameliorating effect on the HIV-induced CNS pathology (Pizzo et aL, 1988; DeCarli et al., 1991) . Thus, the results of these studies indicate that FIV is a good model for examining the early neurological effects of lentiviruses and that FIV may serve as an effective system to test therapeutic approaches that are directed toward the neurological form of the disease.
